FIELD: medicine.
SUBSTANCE: claimed viscoelastic based on 1.5-2.5 % methylcellulose contains additionally 0.0125-0.025 % dipivephrin hydrochloride solution and 0.0005-0.01 % of benzalconium chloride as stabilizer.
EFFECT: viscoelastic for prevention of eye tissues during intraocular interferences.
2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| VISCOPROTECTOR FOR PROTECTION OF INTRAOCULAR TISSUES | 2009 |
|
RU2411946C1 |
| VISCOELASTIC AGENT FOR PROTECTING EYE TISSUES | 2003 |
|
RU2250100C1 |
| VISCOELASTIC FOR PROTECTION OF INTRAOCULAR TISSUES | 2007 |
|
RU2339384C1 |
| METHOD OF SIMULTANEOUS SURGICAL TREATMENT OF CATARACT IN COMBINATION WITH DECOMPENSATED GLAUCOMA OPERATED EARLIER | 2008 |
|
RU2372065C1 |
| METHOD FOR SIMULTANEOUS PERFORMING OPERATION ON CATARACT AND GLAUCOMA | 2003 |
|
RU2240087C1 |
| METHOD OF COMBINED SURGICAL TREATMENT OF SECONDARY GLAUCOMA CAUSED BY DISLOCATION OF AN INTRAOCULAR LENS | 2018 |
|
RU2672383C1 |
| METHOD OF SURGICAL MANAGEMENT OF CATARACT IN PATIENTS WITH SHORT ANTEROPOSTERIOR AXIS OF EYE | 2015 |
|
RU2611886C1 |
| METHOD FOR TREATING CATARACT AGGRAVATED BY OPEN ANGLE GLAUCOMA | 1998 |
|
RU2173549C2 |
| SURGICAL METHOD FOR TREATING THE CASES OF GLAUCOMA AND CATARACT COMBINATION | 2000 |
|
RU2160573C1 |
| METHOD FOR EXPLANTATION OF A SINGLE-PIECE DISLOCATED INTRAOCULAR LENS IN A CAPSULAR SAC | 2020 |
|
RU2741375C1 |
